Intra-Cellular Therapies Inc. buy Royal Bank of Canada
Start price
23.02.24
/
50%
€64.80
Target price
23.02.25
€79.43
Performance (%)
-6.64%
Price
10.05.24
€60.50
Summary
This prediction is currently active. With a performance of -6.64%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 23.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -5.469% | -5.469% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $86.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€62.50
03.04.24
03.04.24
€79.68
03.04.25
03.04.25
-3.20%
10.05.24
10.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.60
31.01.24
31.01.24
€79.15
31.01.25
31.01.25
-4.87%
10.05.24
10.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€51.40
03.11.23
03.11.23
€70.83
03.11.24
03.11.24
20.62%
10.05.24
10.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.50
04.08.23
04.08.23
€71.56
04.08.24
04.08.24
13.08%
10.05.24
10.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.00
02.03.23
02.03.23
€67.06
02.03.24
02.03.24
50.68%
03.03.24
03.03.24